Simple Summary “Scanxiety”, or the distress and/or anxiety occurring before, during, and
after cancer-related imaging/scans, is an upsetting experience during and following cancer …

Purpose of review This review sought to define the emerging roles of urinary tumor DNA
(utDNA) for diagnosis, monitoring, and treatment of bladder cancer. Building from early …

Objectives To investigate prospectively the clinical utility and influence on decision‐making
of Bladder EpiCheck™, a non‐invasive urine test, in the surveillance of non‐muscle …

Abstract “Replace Cysto” is a multisite randomized phase 2 trial including 240 participants
with low-grade intermediate-risk non–muscle-invasive bladder cancer, in which participants …

Background Bladder cancer is a kind of tumors with a high recurrence rate. The
improvement of the cure rate and prognosis of bladder tumor depends on the accurate …

Non-muscle-invasive bladder cancer (NMIBC) is accompanied with high incidence and
recurrence rates. The extensive need for cystoscopic follow up causes substantial patient …

Purpose To understand supportive care needs among people with non-muscle invasive
bladder cancer (NMIBC). Methods An integrative systematic review was reported using the …

Background Surveilling recurrent urothelial carcinoma (UC) requires frequent cystoscopy,
which is invasive, expensive and time-consuming. An accurate urinary biomarker has the …

Purpose Bladder cancer surveillance is associated with high costs and patient burden.
CxMonitor (CxM), a home urine test, allows patients to skip their scheduled surveillance …

Background: Although approximately 75% of bladder cancers are non-muscle invasive
(NMIBC) at diagnosis, most research tends to focus on invasive disease (eg, experiences …